Pharming Group N.V.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 34.5% | 34.5% | 15.8% |
| FY2020 | 20.6% | 20.6% | 9.0% |
| FY2021 | 8.3% | 8.3% | 4.0% |
| FY2022 | 6.7% | 6.7% | 3.2% |
| FY2023 | -4.8% | -4.8% | -2.3% |
| FY2024 | -5.4% | -5.4% | -3.0% |
| FY2025 | 1.0% | 1.0% | 0.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 34.5% | 34.5% | 15.8% |
| FY2020 | 20.6% | 20.6% | 9.0% |
| FY2021 | 8.3% | 8.3% | 4.0% |
| FY2022 | 6.7% | 6.7% | 3.2% |
| FY2023 | -4.8% | -4.8% | -2.3% |
| FY2024 | -5.4% | -5.4% | -3.0% |
| FY2025 | 1.0% | 1.0% | 0.6% |